Insider transactions

EDGAR

Janux Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-17.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
10 transactions, 28,463 shares
Sum of shares × price per share: 457,074.3561

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–43 of 43

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-07-31 Filed 2026-07-31Campbell David Alan Director · Officer: President and CEO
G

Bona fide gift

Common Stock
Disposed (D)123,8400—264,742Direct (D) No— Open filing 0001864158-26-000006 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-10Campbell David Alan Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)7,0004.21
29,470

Derived: shares × price per share. Exact value 29470.00.

388,582Direct (D) No— Open filing 0001864158-26-000004 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-10Campbell David Alan Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (7,000) — exercise price 4.21
Disposed (D)7,0000—697,550Direct (D) No
F1
  • F1 Immediately exercisable.
Open filing 0001864158-26-000004 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12Kung Winston Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,5000—11,750Direct (D) No
F1
  • F1 Represents the grant of restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.
Open filing 0001666963-26-000003 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12Kung Winston Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (15,500) — exercise price 13.66
Acquired (A)15,5000—15,500Direct (D) No
F2
  • F2 The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.
Open filing 0001666963-26-000003 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,5000—11,750Indirect (I) See footnotesNo
F1, F2, F3
  • F1 Represents the grant of restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to Dr. Jake Simson's continuous service on such date.
  • F2 RA Capital Management, L.P. (the Adviser) is the investment manager for RA Capital Healthcare Fund, L.P. (the Fund) and RA Capital Nexus Fund II, L.P. (the Nexus Fund II). The general partner of the Adviser is RA Capital Management GP, LLC (the Adviser GP), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund II, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
  • F3 Under Dr. Simson's arrangement with the Adviser, Dr. Simson holds the option and RSU for the benefit of the Fund and the Nexus Fund II. Dr. Simson is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option or settlement of the RSUs, as applicable, which will offset advisory fees owed by the Fund and the Nexus Fund II to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and RSUs and underlying common stock.
Open filing 0001231919-26-000631 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund II, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (15,500) — exercise price 13.66
Acquired (A)15,5000—15,500Indirect (I) See FootnotesNo
F6, F2, F3
  • F6 The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to Dr. Simson's continuous service on each such date.
  • F2 RA Capital Management, L.P. (the Adviser) is the investment manager for RA Capital Healthcare Fund, L.P. (the Fund) and RA Capital Nexus Fund II, L.P. (the Nexus Fund II). The general partner of the Adviser is RA Capital Management GP, LLC (the Adviser GP), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund II, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
  • F3 Under Dr. Simson's arrangement with the Adviser, Dr. Simson holds the option and RSU for the benefit of the Fund and the Nexus Fund II. Dr. Simson is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option or settlement of the RSUs, as applicable, which will offset advisory fees owed by the Fund and the Nexus Fund II to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and RSUs and underlying common stock.
Open filing 0001231919-26-000631 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12CAPPS VICKIE L Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,5000—79,598Direct (D) No
F1
  • F1 Represents the grant of restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.
Open filing 0001248190-26-000002 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12CAPPS VICKIE L Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (15,500) — exercise price 13.66
Acquired (A)15,5000—15,500Direct (D) No
F2
  • F2 The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.
Open filing 0001248190-26-000002 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12Hernday Natasha Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,5000—15,481Direct (D) No
F1
  • F1 Represents the grant of restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.
Open filing 0001780547-26-000004 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12Hernday Natasha Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (15,500) — exercise price 13.66
Acquired (A)15,5000—15,500Direct (D) No
F2
  • F2 The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.
Open filing 0001780547-26-000004 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12Simson Jake Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,5000—11,750Direct (D) No
F1, F2
  • F1 Represents the grant of restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.
  • F2 Under the Reporting Person's arrangement with RA Capital Management, L.P. (the Advisor), the Reporting Person holds the option and RSUs reported for the benefit of the RA Capital Healthcare Fund, L.P. (the Fund) and the RA Capital Nexus Fund II, L.P. (the Nexus Fund II). The Reporting Person is obligated to turn over to the Advisor any net cash or stock received upon exercise of the option or settlement of the RSUs, as applicable, which will offset advisory fees owed by the Fund and the Nexus Fund II to the Advisor. The Reporting Person therefore disclaims beneficial ownership of the option and RSUs and underlying common stock.
Open filing 0001863094-26-000002 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12Simson Jake Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (15,500) — exercise price 13.66
Acquired (A)15,5000—15,500Direct (D) No
F3, F2
  • F3 The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.
  • F2 Under the Reporting Person's arrangement with RA Capital Management, L.P. (the Advisor), the Reporting Person holds the option and RSUs reported for the benefit of the RA Capital Healthcare Fund, L.P. (the Fund) and the RA Capital Nexus Fund II, L.P. (the Nexus Fund II). The Reporting Person is obligated to turn over to the Advisor any net cash or stock received upon exercise of the option or settlement of the RSUs, as applicable, which will offset advisory fees owed by the Fund and the Nexus Fund II to the Advisor. The Reporting Person therefore disclaims beneficial ownership of the option and RSUs and underlying common stock.
Open filing 0001863094-26-000002 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12Barrett Ronald W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,5000—11,750Direct (D) No
F1
  • F1 Represents the grant of restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.
Open filing 0001326330-26-000002 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12Barrett Ronald W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (15,500) — exercise price 13.66
Acquired (A)15,5000—15,500Direct (D) No
F2
  • F2 The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.
Open filing 0001326330-26-000002 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12DOBMEIER ERIC Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,5000—15,481Direct (D) No
F1
  • F1 Represents the grant of restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date.
Open filing 0001202785-26-000002 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12DOBMEIER ERIC Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (15,500) — exercise price 13.66
Acquired (A)15,5000—15,500Direct (D) No
F2
  • F2 The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date.
Open filing 0001202785-26-000002 Read from the filing’s XML Dispute this row
2026-06-02 Filed 2026-06-04Doyle Janeen Noel Officer: Chief Corp. Bus. Dev. Ofcr
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,05914.029
56,943.711

Derived: shares × price per share. Exact value 56943.711.

75,941Direct (D) No
F1, F2
  • F1 The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • F2 The weighted average sale price for the transaction reported was $14.029 and the range of prices were between $13.96 and $14.03. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002069239-26-000005 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-13Dobek Maria Officer: Vice President, Accounting
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,03814.17
28,878.46

Derived: shares × price per share. Exact value 28878.46.

32,270Direct (D) No— Open filing 0002032671-26-000004 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-04Go William Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)44,0000—44,000Direct (D) No
F1
  • F1 Represents the grant of restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on February 1, 2027.
Open filing 0002108554-26-000004 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-04Go William Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock option (right to buy) — underlying Common Stock (154,000) — exercise price 13.99
Acquired (A)154,0000—154,000Direct (D) No
F2
  • F2 25% of the shares subject to the option vest on February 26, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.
Open filing 0002108554-26-000004 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02Doyle Janeen Noel Officer: Chief Corp. Bus. Dev. Ofcr
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)36,0000—80,000Direct (D) No
F1
  • F1 Represents the grant of restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.
Open filing 0002069239-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02Doyle Janeen Noel Officer: Chief Corp. Bus. Dev. Ofcr
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock option (right to buy) — underlying Common Stock (126,000) — exercise price 13.65
Acquired (A)126,0000—126,000Direct (D) No
F2
  • F2 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.
Open filing 0002069239-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02Meyer Andrew Hollman Officer: Chief Business Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,87913.73
25,798.67

Derived: shares × price per share. Exact value 25798.67.

83,095Direct (D) No
F1
  • F1 The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.
Open filing 0001864159-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02McIver Zachariah Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,71413.73
37,263.22

Derived: shares × price per share. Exact value 37263.22.

23,286Direct (D) No
F1
  • F1 The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.
Open filing 0002050056-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02McIver Zachariah Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)29,0000—52,286Direct (D) No
F2
  • F2 Represents the grant of restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.
Open filing 0002050056-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02McIver Zachariah Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock option (right to buy) — underlying Common Stock (101,500) — exercise price 13.65
Acquired (A)101,5000—101,500Direct (D) No
F3
  • F3 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.
Open filing 0002050056-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02DiRaimondo Thomas Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,50513.73
34,393.65

Derived: shares × price per share. Exact value 34393.65.

124,425Direct (D) No
F1, F2
  • F1 The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • F2 Includes 4,049 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the Plan) on May 15, 2025. Also, on January 3, 2025, the Reporting Person filed a Form 4 which inadvertently reported an aggregate of 7,781 shares acquired under the Plan. In fact, 5,432 of the shares were already reported as acquired by the Reporting Person under the Plan on a Form 3 filed on January 3, 2024 and 1,406 of the shares were reported as acquired by the Reporting Person under the Plan on a Form 4 filed on September 27, 2024.
Open filing 0002005618-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02DiRaimondo Thomas Officer: Chief Scientific Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)31,4000—155,825Direct (D) No
F3
  • F3 Represents the grant of restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.
Open filing 0002005618-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02DiRaimondo Thomas Officer: Chief Scientific Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock option (right to buy) — underlying Common Stock (109,900) — exercise price 13.65
Acquired (A)109,9000—109,900Direct (D) No
F4
  • F4 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.
Open filing 0002005618-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02Dobek Maria Officer: Vice President, Accounting
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,46213.73
20,073.26

Derived: shares × price per share. Exact value 20073.26.

15,373Direct (D) No
F1, F2
  • F1 The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • F2 Includes 2,834 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on May 15, 2025.
Open filing 0002032671-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02Dobek Maria Officer: Vice President, Accounting
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)18,9350—34,308Direct (D) No
F3
  • F3 Represents the grant of restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.
Open filing 0002032671-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02Dobek Maria Officer: Vice President, Accounting
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock option (right to buy) — underlying Common Stock (42,600) — exercise price 13.65
Acquired (A)42,6000—42,600Direct (D) No
F4
  • F4 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.
Open filing 0002032671-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02Campbell David Alan Director · Officer: President and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,07213.73
110,828.56

Derived: shares × price per share. Exact value 110828.56.

284,982Direct (D) No
F1
  • F1 The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.
Open filing 0001864158-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02Campbell David Alan Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)96,6000—381,582Direct (D) No
F2
  • F2 Represents the grant of restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.
Open filing 0001864158-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02Campbell David Alan Director · Officer: President and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock option (right to buy) — underlying Common Stock (338,100) — exercise price 13.65
Acquired (A)338,1000—338,100Direct (D) No
F3
  • F3 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.
Open filing 0001864158-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02Winter Charles M. Officer: Chief Technical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,40113.73
32,965.73

Derived: shares × price per share. Exact value 32965.73.

77,721Direct (D) No
F1, F2
  • F1 The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • F2 Includes 2,834 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on May 15, 2025.
Open filing 0001960264-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02Winter Charles M. Officer: Chief Technical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)28,6000—106,321Direct (D) No
F3
  • F3 Represents the grant of restricted stock units (RSUs), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027.
Open filing 0001960264-26-000002 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-02Winter Charles M. Officer: Chief Technical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock option (right to buy) — underlying Common Stock (100,100) — exercise price 13.65
Acquired (A)100,1000—100,100Direct (D) No
F4
  • F4 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.
Open filing 0001960264-26-000002 Read from the filing’s XML Dispute this row
2025-12-01 Filed 2025-12-03Meyer Andrew Hollman Officer: Chief Business Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)3,33310.59
35,296.47

Derived: shares × price per share. Exact value 35296.47.

88,307Direct (D) Yes— Open filing 0001864159-25-000006 Read from the filing’s XML Dispute this row
2025-12-01 Filed 2025-12-03Meyer Andrew Hollman Officer: Chief Business Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,70032.8548
88,707.96

Derived: shares × price per share. Exact value 88707.9600.

85,607Direct (D) Yes
F1, F2
  • F1 The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024.
  • F2 The weighted average sale price for the transaction reported was $32.8548 and the range of prices were between $32.27 and $33.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0001864159-25-000006 Read from the filing’s XML Dispute this row
2025-12-01 Filed 2025-12-03Meyer Andrew Hollman Officer: Chief Business Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)63333.5247
21,221.1351

Derived: shares × price per share. Exact value 21221.1351.

84,974Direct (D) Yes
F1, F3
  • F1 The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024.
  • F3 The weighted average sale price for the transaction reported was $33.5247 and the range of prices were between $33.28 and $33.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0001864159-25-000006 Read from the filing’s XML Dispute this row
2025-12-01 Filed 2025-12-03Meyer Andrew Hollman Officer: Chief Business Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (3,333) — exercise price 10.59
Disposed (D)3,3330—114,768Direct (D) Yes
F4
  • F4 Immediately exercisable.
Open filing 0001864159-25-000006 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,793 filings read, the latest filed 2026-11-16. Prior quarter ending 2026-06-30: 9,164 filings read.

Showing 1–50 of 217

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
RA CAPITAL MANAGEMENT, L.P. 11,189,693 SH193,357,895 dollarsUnchanged Prior quarter: 11,189,693Open filing 0001104659-26-128411 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager6,534,742 SH112,920,330 dollarsHigher by 400,075 Prior quarter: 6,134,667Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Prosight Management, LP 2,943,200 SH50,858,496 dollarsLower by 861,281 Prior quarter: 3,804,481Open filing 0001420506-26-002713 Filed 2026-11-13 Dispute this row
FEDERATED HERMES, INC. Partly reported under another manager2,594,722 SH44,836,796 dollarsHigher by 241,795 Prior quarter: 2,352,927Open filing 0001623632-26-001675 Filed 2026-11-12 Dispute this row
FMR LLC Partly reported under another manager2,510,089 SH43,374,338 dollarsHigher by 97,264 Prior quarter: 2,412,825Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
STATE STREET CORP Partly reported under another manager2,310,949 SH39,933,199 dollarsLower by 693,950 Prior quarter: 3,004,899Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 2,153,138 SH37,206,225 dollarsHigher by 295,787 Prior quarter: 1,857,351Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
TWO SIGMA INVESTMENTS, LP 1,845,429 SH31,889,013 dollarsHigher by 638,179 Prior quarter: 1,207,250Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
TCG Crossover Management, LLC 1,789,617 SH30,924,582 dollarsUnchanged Prior quarter: 1,789,617Open filing 0001214659-26-014306 Filed 2026-11-16 Dispute this row
Point72 Asset Management, L.P. 1,579,984 SH27,302,124 dollarsLower by 413,853 Prior quarter: 1,993,837Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
D. E. Shaw Co., Inc. Partly reported under another manager1,509,361 SH26,081,758 dollarsHigher by 412,852 Prior quarter: 1,096,509Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 1,452,698 SH25,102,621 dollarsHigher by 121,988 Prior quarter: 1,330,710Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager1,281,018 SH22,140,618 dollarsHigher by 76,868 Prior quarter: 1,204,150Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Alyeska Investment Group, L.P. 1,095,401 SH18,928,529 dollarsLower by 551,739 Prior quarter: 1,647,140Open filing 0001172661-26-005329 Filed 2026-11-16 Dispute this row
Nuveen, LLC Partly reported under another manager1,044,772 SH18,053,661 dollarsHigher by 947,652 Prior quarter: 97,120Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager1,027,073 SH17,747,821 dollarsHigher by 74,398 Prior quarter: 952,675Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager961,587 SH16,616,223 dollarsHigher by 124,621 Prior quarter: 836,966Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager920,679 SH15,909,333 dollarsLower by 586,681 Prior quarter: 1,507,360Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
Nantahala Capital Management, LLC 857,334 SH14,814,732 dollarsLower by 762,494 Prior quarter: 1,619,828Open filing 0001104659-26-127125 Filed 2026-11-13 Dispute this row
ADAR1 Capital Management, LLC 823,876 SH14,236,577 dollarsHigher by 402,995 Prior quarter: 420,881Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager749,137 SH12,945,087 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
Qube Research Technologies Ltd 647,261 SH11,184,670 dollarsLower by 54,796 Prior quarter: 702,057Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
ORBIMED ADVISORS LLC 524,700 SH9,066,816 dollarsUnchanged Prior quarter: 524,700Open filing 0001172661-26-005349 Filed 2026-11-16 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager506,368 SH8,750,038 dollarsLower by 404,092 Prior quarter: 910,460Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager496,535 SH8,580,125 dollarsLower by 704,202 Prior quarter: 1,200,737Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
HRT FINANCIAL LP 445,162 SH7,692 dollarsLower by 63,139 Prior quarter: 508,301Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 442,007 SH7,637,881 dollarsHigher by 72,816 Prior quarter: 369,191Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager441,288 SH7,625,021 dollarsHigher by 81,563 Prior quarter: 359,725Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager416,764 SH7,201,682 dollarsHigher by 18,398 Prior quarter: 398,366Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
Squarepoint Ops LLC Partly reported under another manager390,907 SH6,754,873 dollarsLower by 141,414 Prior quarter: 532,321Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 376,496 SH6,505,851 dollarsUnchanged Prior quarter: 376,496Open filing 0002011081-26-000015 Filed 2026-11-12 Dispute this row
Woodline Partners LP 371,532 SH6,420,073 dollarsHigher by 1,500 Prior quarter: 370,032Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
Rock Springs Capital Management LP 367,009 SH6,341,916 dollarsUnchanged Prior quarter: 367,009Open filing 0001172661-26-005279 Filed 2026-11-16 Dispute this row
Jump Financial, LLC Partly reported under another manager344,611 SH5,954,877 dollarsLower by 17,054 Prior quarter: 361,665Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row
VANGUARD FIDUCIARY TRUST CO 329,243 SH5,689,319 dollarsHigher by 13,972 Prior quarter: 315,271Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Connor, Clark Lunn Investment Management Ltd. 312,051 SH5,392,241 dollarsHigher by 178,181 Prior quarter: 133,870Open filing 0001596800-26-000018 Filed 2026-11-10 Dispute this row
JANE STREET GROUP, LLC Option: Put Partly reported under another manager308,100 SH5,323,968 dollarsNot in the prior quarter’s filings read Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager250,215 SH4,323,714 dollarsHigher by 142,138 Prior quarter: 108,077Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
PANAGORA ASSET MANAGEMENT INC 223,072 SH3,854,684 dollarsLower by 46,041 Prior quarter: 269,113Open filing 0000883677-26-000011 Filed 2026-11-12 Dispute this row
MILLENNIUM MANAGEMENT LLC 219,110 SH3,786,221 dollarsLower by 285,434 Prior quarter: 504,544Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
Squadron Capital Management LLC 215,000 SH3,715,200 dollarsNot in the prior quarter’s filings read Open filing 0002050709-26-000036 Filed 2026-11-16 Dispute this row
Allspring Global Investments Holdings, LLC Partly reported under another manager209,002 SH3,544,674 dollarsHigher by 42,910 Prior quarter: 166,092Open filing 0001890906-26-000078 Filed 2026-11-04 Dispute this row
Balyasny Asset Management L.P. 208,222 SH3,598,076 dollarsLower by 3,413 Prior quarter: 211,635Open filing 0001193125-26-463223 Filed 2026-11-16 Dispute this row
Quantinno Capital Management LP 206,800 SH3,573,504 dollarsHigher by 136,563 Prior quarter: 70,237Open filing 0001759654-26-000011 Filed 2026-11-13 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager173,811 SH2,946,097 dollarsLower by 4,724 Prior quarter: 178,535Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
UBS Group AG Partly reported under another manager171,469 SH2,962,985 dollarsHigher by 20,768 Prior quarter: 150,701Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Creative Planning Partly reported under another manager168,202 SH2,906,524 dollarsHigher by 123,970 Prior quarter: 44,232Open filing 0001540235-26-000006 Filed 2026-11-02 Dispute this row
Man Group plc Partly reported under another manager161,117 SH2,784,102 dollarsLower by 87,684 Prior quarter: 248,801Open filing 0001637460-26-000004 Filed 2026-11-16 Dispute this row
BML Capital Management, LLC 151,126 SH2,611,457 dollarsLower by 3,835 Prior quarter: 154,961Open filing 0001754960-26-000981 Filed 2026-11-06 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager142,439 SH2,461,347 dollarsHigher by 7,367 Prior quarter: 135,072Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • ALGERT GLOBAL LLC 1,110,889 SH
  • Sixth Street Partners Management Company, L.P. 369,191 SH
  • Jupiter Topco LLC 172,229 SH
  • Thrivent Financial for Lutherans 115,030 SH
  • CAPITAL FUND MANAGEMENT S.A. 101,972 SH
  • AXQ CAPITAL, LP 47,508 SH
  • TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 38,875 SH
  • MARSHALL WACE, LLP 32,734 SH
  • Hudson Bay Capital Management LP 30,000 SH
  • SG Americas Securities, LLC 29,278 SH
  • DRW Securities, LLC 19,749 SH
  • ALLSTATE CORP 18,500 SH
  • MML INVESTORS SERVICES, LLC 17,138 SH
  • Brevan Howard Capital Management LP 16,204 SH
  • PRELUDE CAPITAL MANAGEMENT, LLC 13,800 SH
  • OXFORD ASSET MANAGEMENT LLP 12,844 SH
  • NEW YORK STATE COMMON RETIREMENT FUND 11,746 SH
  • INTECH INVESTMENT MANAGEMENT LLC 11,473 SH
  • Mitsubishi UFJ Trust Banking Corp 8,832 SH
  • Pacer Advisors, Inc. 895 SH
  • SUMMIT SECURITIES GROUP LLC 487 SH
  • Integrated Wealth Concepts LLC 453 SH
  • CITIGROUP INC 200 SH
  • CITIGROUP INC 200 SH
  • GROUP ONE TRADING LLC 128 SH
  • Optiver Holding B.V. 118 SH
  • Aventura Private Wealth, LLC 88 SH
  • Avion Wealth 36 SH
  • Cornerstone Planning Group LLC 30 SH
  • BESSEMER GROUP INC 28 SH
  • Ares Financial Consulting, LLC 25 SH
  • Wealth Enhancement Trust Services, Inc. 23 SH
  • IFP Advisors, Inc 1 SH
  • HUNTINGTON NATIONAL BANK 1 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
W. Lawrence Hawkins Common Stock, $0.001 par value per share5.153,150,45011/10/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 1Open filing 0001617201-26-000008 Dispute this row
Prosight Fund, LP Common Stock, $0.001 par value per share0.25155,02211/10/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 1Open filing 0001617201-26-000008 Dispute this row
Prosight Plus Fund, LP Common Stock, $0.001 par value per share0.86525,31911/10/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 1Open filing 0001617201-26-000008 Dispute this row
Prosight Management, LP Common Stock, $0.001 par value per share5.143,144,20011/10/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 1Open filing 0001617201-26-000008 Dispute this row
Prosight Partners, LLC Common Stock, $0.001 par value per share5.143,144,20011/10/2026 Filed 2026-11-13SCHEDULE 13G/AAmendment 1Open filing 0001617201-26-000008 Dispute this row
Point72 Asset Management, L.P. Common Stock, par value $0.001 per share3.31,993,837.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-005493 Dispute this row
Point72 Capital Advisors, Inc. Common Stock, par value $0.001 per share3.31,993,837.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-005493 Dispute this row
Steven A. Cohen Common Stock, par value $0.001 per share3.31,993,837.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-005493 Dispute this row
JANUS HENDERSON GROUP Ltd. Common Stock0.3172,22906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 6Open filing 0001274173-26-000200 Dispute this row
BlackRock, Inc. Common Stock6.74,098,45706/30/2026 Filed 2026-07-28SCHEDULE 13G/AAmendment 1Open filing 0002012383-26-002544 Dispute this row
Point72 Asset Management, L.P. Common Stock, par value $0.001 per share5.03,069,759.0004/28/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0000919574-26-002474 Dispute this row
Point72 Capital Advisors, Inc. Common Stock, par value $0.001 per share5.03,069,759.0004/28/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0000919574-26-002474 Dispute this row
Steven A. Cohen Common Stock, par value $0.001 per share5.03,069,759.0004/28/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0000919574-26-002474 Dispute this row
Point72 Asset Management, L.P. Common Stock, par value $0.001 per share5.03,069,759.0004/28/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0000919574-26-002475 Dispute this row
Point72 Capital Advisors, Inc. Common Stock, par value $0.001 per share5.03,069,759.0004/28/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0000919574-26-002475 Dispute this row
Steven A. Cohen Common Stock, par value $0.001 per share5.03,069,759.0004/28/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0000919574-26-002475 Dispute this row
JANUS HENDERSON GROUP PLC Common Stock6.94,196,40903/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 5Open filing 0001274173-26-000148 Dispute this row
STATE STREET CORPORATION COMMON STOCK4.12,464,017.0003/31/2026 Filed 2026-05-12SCHEDULE 13GOpen filing 0000093751-26-000251 Dispute this row
FMR LLC COMMON STOCK4.22,535,723.6303/31/2026 Filed 2026-05-06SCHEDULE 13G/AAmendment 5Open filing 0000315066-26-001219 Dispute this row
Abigail P. Johnson COMMON STOCK4.22,535,723.6303/31/2026 Filed 2026-05-06SCHEDULE 13G/AAmendment 5Open filing 0000315066-26-001219 Dispute this row
Prosight Management, LP Common Stock, $0.001 par value per share5.23,150,970.0002/03/2026 Filed 2026-02-06SCHEDULE 13GOpen filing 0001104659-26-011545 Dispute this row
Prosight Fund, LP Common Stock, $0.001 par value per share0.2148,416.0002/03/2026 Filed 2026-02-06SCHEDULE 13GOpen filing 0001104659-26-011545 Dispute this row
Prosight Plus Fund, LP Common Stock, $0.001 par value per share1.1685,220.0002/03/2026 Filed 2026-02-06SCHEDULE 13GOpen filing 0001104659-26-011545 Dispute this row
Prosight Partners, LLC Common Stock, $0.001 par value per share5.23,150,970.0002/03/2026 Filed 2026-02-06SCHEDULE 13GOpen filing 0001104659-26-011545 Dispute this row
W. Lawrence Hawkins Common Stock, $0.001 par value per share5.33,157,220.0002/03/2026 Filed 2026-02-06SCHEDULE 13GOpen filing 0001104659-26-011545 Dispute this row
JANUS HENDERSON GROUP PLC Common Stock8.95,350,45312/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 4Open filing 0001274173-26-000086 Dispute this row
STATE STREET CORPORATION COMMON STOCK6.43,853,951.0012/31/2025 Filed 2026-02-09SCHEDULE 13GOpen filing 0000093751-26-000058 Dispute this row
FMR LLC COMMON STOCK5.83,512,384.0012/31/2025 Filed 2026-01-08SCHEDULE 13G/AAmendment 4Open filing 0000315066-26-000045 Dispute this row
Abigail P. Johnson COMMON STOCK5.83,512,384.0012/31/2025 Filed 2026-01-08SCHEDULE 13G/AAmendment 4Open filing 0000315066-26-000045 Dispute this row
JANUS HENDERSON GROUP PLC Common Stock10.06,033,94910/31/2025 Filed 2025-11-07SCHEDULE 13G/AAmendment 3Open filing 0001274173-25-000262 Dispute this row
JANUS HENDERSON GROUP PLC Common Stock7.54,460,33206/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 2Open filing 0001274173-25-000228 Dispute this row
Paradigm BioCapital Advisors LP Common Stock, $0.001 par value per share4.92,920,258.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 2Open filing 0001104659-25-078664 Dispute this row
Paradigm BioCapital Advisors GP LLC Common Stock, $0.001 par value per share4.92,920,258.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 2Open filing 0001104659-25-078664 Dispute this row
Senai Asefaw, M.D. Common Stock, $0.001 par value per share4.92,920,258.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 2Open filing 0001104659-25-078664 Dispute this row
Paradigm BioCapital International Fund Ltd. Common Stock, $0.001 par value per share4.42,593,376.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 2Open filing 0001104659-25-078664 Dispute this row
Adage Capital Management, L.P. Common Stock, $0.001 par value per share4.272,525,000.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 1Open filing 0000902664-25-003510 Dispute this row
Robert Atchinson Common Stock, $0.001 par value per share4.272,525,000.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 1Open filing 0000902664-25-003510 Dispute this row
Phillip Gross Common Stock, $0.001 par value per share4.272,525,000.0006/30/2025 Filed 2025-08-12SCHEDULE 13G/AAmendment 1Open filing 0000902664-25-003510 Dispute this row
BlackRock, Inc. Common Stock5.73,345,66406/30/2025 Filed 2025-07-17SCHEDULE 13GOpen filing 0002052113-25-003076 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,212,651 filings read, dated 2004-06-14 to 2026-11-16: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
2022130,393
2023199,811
2024209,823
2025235,520
2026260,165

Filings made before the SEC required XML are listed, not extracted.

Back to Janux Therapeutics, Inc.